Suzanne Blaug's most recent trade in FibroGen Inc was a trade of 70,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 5, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
FibroGen Inc | Suzanne Blaug | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 70,000 | 70,000 | - | - | Stock Option (Right to Buy) | |
FibroGen Inc | Suzanne Blaug | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 12,666 | 12,666 | - | - | Stock Option (Right to Buy) | |
FibroGen Inc | Suzanne Blaug | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 8,289 | 38,114 (0%) | 0% | 0 | Common Stock | |
FibroGen Inc | Suzanne Blaug | Director | Sale of securities on an exchange or to another person at price $ 17.51 per share. | 07 Jun 2023 | 5,169 | 29,594 (0%) | 0% | 17.5 | 90,509 | Common Stock |
FibroGen Inc | Suzanne Blaug | Director | Sale of securities on an exchange or to another person at price $ 16.73 per share. | 07 Jun 2023 | 3,351 | 34,763 (0%) | 0% | 16.7 | 56,062 | Common Stock |
FibroGen Inc | Suzanne Blaug | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 25,684 | 25,684 | - | - | Stock Option (Right to Buy) | |
FibroGen Inc | Suzanne Blaug | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 15,777 | 29,825 (0%) | 0% | 0 | Common Stock | |
FibroGen Inc | Suzanne Blaug | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 7,800 | 7,800 | - | - | Stock Option (Right to Buy) | |
FibroGen Inc | Suzanne Blaug | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 4,700 | 14,048 (0%) | 0% | 0 | Common Stock | |
FibroGen Inc | Suzanne Blaug | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2020 | 7,800 | 7,800 | - | - | Stock Option (Right to Buy) | |
FibroGen Inc | Suzanne Blaug | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2020 | 4,700 | 9,348 (0%) | 0% | 0 | Common Stock |